Clinical, biochemical (PSA) and radiographic benefit with sunitinib as a single agent in metastatic chemoresistant and hormone-refractory prostate cancer (HRPC) patients
- Castellano, D.
- Gonzalez Larriba, J.
- Anton Aparicio, L. M.
- Casinello, J.
- Grande, E.
- Esteban, E.
- Sepulveda, J.
- Rodriguez, A.
- Ghanem Canete, I.
ISSN: 1359-6349
Año de publicación: 2009
Volumen: 7
Número: 2
Páginas: 417-417
Congreso: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology
Tipo: Aportación congreso